Mellitus Health is a health care startup founded in 2015, headquartered in the United States, with a focus on simplifying diabetes clinical care. The company specializes in developing insulin dosage adjustment software for the diabetes care marketplace. This software aims to provide an effective and low-cost method for a variety of healthcare specialists and non-specialists to adjust insulin doses, ultimately improving diabetes control and preventing diabetic complications such as retinopathy, kidney failure, neuropathy, and lower extremity amputations. The company was founded by Dr. Mayer B. Davidson, a renowned figure in diabetes treatment and research. Dr. Davidson, a Professor of Medicine at both UCLA and Charles R. Drew University, has an extensive background in diabetes, with significant experience and credibility in the field. He has authored numerous scientific papers, book chapters, reviews, and editorials in addition to multiple books, establishing his authority in the diabetes domain. Mellitus Health's approach holds promise in widening the type of healthcare providers who can accurately adjust insulin doses and thereby significantly reduce the overall costs of diabetes care. While the startup does not have publicly available information about its latest investment or investors, its innovative solution and the involvement of a respected industry expert make it an intriguing prospect for potential venture capital interest.
There is no investment information
No recent news or press coverage available for Mellitus Health.